文献速递神经重症与神经感染脑血管病

N-乙酰半胱氨酸靶向5-脂氧合酶衍生的毒性脂质,并可与前列腺素E2协同抑制铁死亡,改善小鼠出血性卒中后的结局

N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice.
PubMed 文献 · Ann Neurol · 2018-11-29

该研究在培养神经元中用血红素模拟铁死亡和出血性卒中,在小鼠和大鼠中用胶原酶纹状体输注模拟脑出血(ICH),通过化学生物学、靶向脂质组学、ALOX5敲除小鼠和病毒基因转移探讨N-乙酰半胱氨酸(NAC)的作用机制。NAC通过中和花生四烯酸依赖性ALOX5活性产生的毒性脂质来预防铁死亡,其疗效需要谷胱甘肽增加,并与谷胱甘肽依赖性酶抑制反应性脂质相关。NAC损伤后给药可减少小鼠ICH后至少7天的神经元死亡并改善功能恢复,且可与临床已批准的前列腺素E2(PGE2)协同。

要点

  • NAC通过中和ALOX5产生的毒性脂质预防血红素诱导的铁死亡,需谷胱甘肽增加。
  • 小鼠ICH后损伤期给予NAC可减少神经元死亡并改善至少7天的功能恢复。
  • NAC可与临床已批准的PGE2协同,在体外和体内增强保护作用。

核心结论

  • NAC是治疗ICH有前景的保护性疗法,作用于抑制核ALOX5产生毒性花生四烯酸产物,并与外源性保护性PGE2在体外和体内协同。
  • 研究为NAC提供了超越通用抗氧化剂表征的新靶点认识,产生神经保护,并提供可行的联合策略以优化NAC治疗铁死亡相关神经系统疾病(如ICH)的疗效和安全性剂量。

研究设计与样本

  • 在培养神经元中用血红素模拟铁死亡和出血性卒中;在小鼠和大鼠中用胶原酶纹状体输注模拟脑出血(ICH)。
  • 使用化学生物学、靶向脂质组学、花生四烯酸5-脂氧合酶(ALOX5)敲除小鼠和病毒基因转移探讨NAC的药理靶点和作用机制。

主要发现

  • NAC通过中和花生四烯酸依赖性ALOX5活性产生的毒性脂质预防血红素诱导的铁死亡。
  • NAC疗效需要谷胱甘肽增加,并与谷胱甘肽依赖性酶(如谷胱甘肽S-转移酶)抑制反应性脂质相关。
  • 化学或分子脂质过氧化抑制剂可模拟NAC的保护效应。
  • 小鼠ICH后损伤期给予NAC减少神经元死亡并改善至少7天的功能恢复。
  • NAC可与临床已批准的PGE2协同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: N-acetylcysteine (NAC) is a clinically approved thiol-containing redox modulatory compound currently in trials for many neurological and psychiatric disorders. Although generically labeled as an "antioxidant," poor understanding of its site(s) of action is a barrier to its use in neurological practice. Here, we examined the efficacy and mechanism of action of NAC in rodent models of hemorrhagic stroke. METHODS: Hemin was used to model ferroptosis and hemorrhagic stroke in cultured neurons. Striatal infusion of collagenase was used to model intracerebral hemorrhage (ICH) in mice and rats. Chemical biology, targeted lipidomics, arachidonate 5-lipoxygenase (ALOX5) knockout mice, and viral-gene transfer were used to gain insight into the pharmacological targets and mechanism of action of NAC. RESULTS: NAC prevented hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent ALOX5 activity. NAC efficacy required increases in glutathione and is correlated with suppression of reactive lipids by glutathione-dependent enzymes such as glutathione S-transferase. Accordingly, its protective effects were mimicked by chemical or molecular lipid peroxidation inhibitors. NAC delivered postinjury reduced neuronal death and improved functional recovery at least 7 days following ICH in mice and can synergize with clinically approved prostaglandin E2 (PGE2 ). INTERPRETATION: NAC is a promising, protective therapy for ICH, which acted to inhibit toxic arachidonic acid products of nuclear ALOX5 that synergized with exogenously delivered protective PGE2 in vitro and in vivo. The findings provide novel insight into a target for NAC, beyond the generic characterization as an antioxidant, resulting in neuroprotection and offer a feasible combinatorial strategy to optimize efficacy and safety in dosing of NAC for treatment of neurological disorders involving ferroptosis such as ICH. Ann Neurol 2018;84:854-872.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Karuppagounder SS, Alin L, Chen Y, et al. N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice. Ann Neurol. 2018. PMID: 30294906. doi:10.1002/ana.25356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。